Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJRS.L Regulatory News (JRS)

  • There is currently no data for JRS

Sanctions Update

1 Mar 2022 14:21

RNS Number : 2396D
JPMorgan Russian Securities PLC
01 March 2022
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

 

JPMORGAN RUSSIAN SECURITIES PLC

 

Legal Entity Identifier: 549300II3MHI98ZLVH37

 

 

Update from the Board of JPMorgan Russian Securities plc

 

Further to JPMorgan Russian Securities plc's (the Company) announcement on 24th February 2022 regarding the US/EU/UK sanctions, the Board provides the following update:

 

Portfolio:

As at 28th February 2022, the Company's portfolio comprised holdings in locally listed stocks of 49.4%, which the Company is currently unable to trade due to recent restrictions. 40.1% of the Company's holdings are in ADR/GDRs, where trading is disrupted. 10.5% of the Company's assets are held in mostly US Dollar cash and cash equivalents.

The Company currently holds VTB Bank stocks which represented approximately 1.9% of the Company's portfolio as at 25th February 2022. The Company's Manager continues to monitor the impact of the developing sanctions regimes on these stocks.

 

Management Fees:

The Company's Manager has advised the Board of its intention to waive its management fee. The waiver will take effect following payment of the management fee to 28th February 2022 and will apply until further notice.

 

NAV:

The Company will continue to calculate and announce its unaudited NAV on a daily basis. Details of the methodology applied to the calculation of the unaudited NAV will be included in these announcements.

 

Dividends:

As previously announced, the Company will pay its final and first interim dividends to shareholders on 11th March 2022, as declared on 27th January 2022. However, the current sanctions and restrictions in Russia are expected to restrict the Company's ability to pay any further dividends until further notice. It remains the Company's intention to resume quarterly dividend payments once circumstances permit.

 

Share Buyback:

The Company will not be buying back shares whilst current market conditions prevail.

 

 

 

AGM:

The Board continues to recommend that shareholders vote in favour of the resolution for the continuation of the Company at the Annual General Meeting on 4th March 2022. The Board will monitor developments closely thereafter.

 

 

1st March 2022

 

For further information:

 

Paul Winship

Tim Mitchell

JPMorgan Funds Limited 020 7742 4000

 

Hugh Jonathan

Numis Securities plc 020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBSGDXCBGDGDB
Date   Source Headline
28th Sep 202210:59 amRNSNet Asset Value(s)
27th Sep 202211:02 amRNSNet Asset Value(s)
26th Sep 202211:34 amRNSNet Asset Value(s)
23rd Sep 202211:19 amRNSNet Asset Value(s)
22nd Sep 202211:05 amRNSNet Asset Value(s)
21st Sep 202210:57 amRNSNet Asset Value(s)
20th Sep 202211:43 amRNSNet Asset Value(s)
16th Sep 20224:13 pmRNSTen Largest Investments
16th Sep 202211:23 amRNSNet Asset Value(s)
15th Sep 202211:05 amRNSNet Asset Value(s)
14th Sep 202212:35 pmRNSNet Asset Value(s)
13th Sep 202210:51 amRNSNet Asset Value(s)
12th Sep 202211:16 amRNSNet Asset Value(s)
9th Sep 202211:31 amRNSNet Asset Value(s)
8th Sep 202210:48 amRNSNet Asset Value(s)
7th Sep 202211:01 amRNSNet Asset Value(s)
6th Sep 202210:54 amRNSNet Asset Value(s)
5th Sep 202211:24 amRNSNet Asset Value(s)
2nd Sep 202211:39 amRNSNet Asset Value(s)
1st Sep 202212:14 pmRNSNet Asset Value(s)
31st Aug 202211:02 amRNSNet Asset Value(s)
30th Aug 20221:55 pmRNSNet Asset Value(s)
26th Aug 202211:39 amRNSNet Asset Value(s)
25th Aug 202210:53 amRNSNet Asset Value(s)
24th Aug 202210:41 amRNSNet Asset Value(s)
23rd Aug 202211:25 amRNSNet Asset Value(s)
22nd Aug 202211:21 amRNSNet Asset Value(s)
19th Aug 202211:20 amRNSNet Asset Value(s)
18th Aug 202211:16 amRNSNet Asset Value(s)
17th Aug 202212:12 pmRNSNet Asset Value(s)
16th Aug 202211:01 amRNSNet Asset Value(s)
15th Aug 202210:52 amRNSNet Asset Value(s)
12th Aug 20224:38 pmRNSTen Largest Investments
12th Aug 20223:58 pmRNSPortfolio Update
12th Aug 20223:48 pmRNSNet Asset Value(s)
11th Aug 202210:36 amRNSNet Asset Value(s)
10th Aug 202211:27 amRNSNet Asset Value(s)
9th Aug 202210:31 amRNSNet Asset Value(s)
8th Aug 202211:00 amRNSNet Asset Value(s)
5th Aug 202211:03 amRNSNet Asset Value(s)
4th Aug 202210:20 amRNSNet Asset Value(s)
3rd Aug 202210:08 amRNSNet Asset Value(s)
2nd Aug 202211:11 amRNSNet Asset Value(s)
1st Aug 202212:05 pmRNSNet Asset Value(s)
29th Jul 202211:41 amRNSNet Asset Value(s)
28th Jul 202212:14 pmRNSHalf-year Report
28th Jul 202211:01 amRNSNet Asset Value(s)
27th Jul 202211:38 amRNSNet Asset Value(s)
26th Jul 20224:20 pmRNSHolding(s) in Company
26th Jul 202210:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.